U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  FORM 10-Q/A
                                 AMENDMENT No 1

(Mark One)
( X )     QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
          EXCHANGE ACT OF 1934.

                  For the quarterly period ended May 31, 2010

                                       OR

(   )     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
          EXCHANGE ACT OF 1934.

              For the transition period from ________ to ________.

                         Commission File Number 0-12305

                            REPRO-MED SYSTEMS, INC.
             (Exact name of registrant as specified in its charter)

             New York                                     13-3044880
(State or other jurisdiction of                (IRS Employer Identification No.)
 incorporation or organization)

24 Carpenter Road, Chester New York                         10918
(Address of principal executive offices)                  (Zip Code)

       Registrant's telephone number, including area code: (845) 469-2042

              (Former name, former address and former fiscal year,
                         if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. [X] Yes [ ] No

Indicate by check mark whether the registrant has submitted electronically and
posted on its corporate Web site, if any, every Interactive Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T during the
preceding 12 months (or for such shorter period that the registrant was required
to submit and post such files.) Yes [ ] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of "large accelerated filer," "accelerated filer" and "smaller
reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]                        Accelerated filer [ ]
Non-accelerated filer   [ ]                        Smaller reporting company [X]
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). [ ] Yes [X] No

As of May 31, 2010, 35,584,286 shares of common stock, $.01 par value per share,
were outstanding.

<PAGE>

                                EXPLANATORY NOTE

Repro-Med Systems, Inc. (the "Company") is filing this Amendment No. 1 on Form
10-Q/A ("Amendment No. 1") to amend Part II, Item 6 of its Quarterly Report on
Form 10-Q for the quarterly period ended May 31, 2010, originally filed with the
Securities and Exchange Commission on July 15, 2010 (the "Original Quarterly
Report"). Repro-Med Systems, Inc. is filing this Amendment No. 1 for the sole
purpose of amending the wording of Exhibit 31.1 of the Original Quarterly
Report, which did not exactly match the wording required by Item 601(b)(31).

Except as described above, this Amendment No. 1 does not modify or update the
disclosures presented in, or exhibits to, the Original Quarterly Report in any
way. Those sections of the Original Quarterly Report that are unaffected by this
Amendment No. 1 are not included herein. This Amendment No. 1 continues to speak
as of the date of the Original Quarterly Report. Furthermore, this Amendment
does not reflect events occurring after the filing of the Original Quarterly
report. Accordingly, this Amendment should be read in conjunction with the
Original Quarterly Report, as well as the Company's other filings made with the
SEC pursuant to Section 13(a) or 15(d) of the Exchange Act subsequent to the
filing of the Original Quarterly Report.

PART II - OTHER INFORMATION
---------------------------

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
-----------------------------------------

   (a)  EXHIBITS

        31.1  Certification of Chief Executive Officer and Principal Financial
              Officer Pursuant to Section 302 of Sarbanes-Oxley Act 2002

        32.1  Certification of Chief Executive Officer and Principal Financial
              Officer Pursuant to Section 906 of the Sarbanes-Oxley Act 2002 *
__________________
* previously filed

                                     Page 2
<PAGE>

SIGNATURES
----------

Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange
Act of 1934 the Registrant has duly caused this report to be signed on its
behalf by the undersigned; thereunto duly authorized.

REPRO-MED SYSTEMS, INC.

/s/ Andrew I. Sealfon                             March 1, 2011
---------------------
Andrew I. Sealfon, President, Treasurer, Chairman of the Board, Director,
Chief Executive Officer and Principal Financial Officer

                                     Page 3